clinical trial · NCT05094089
Assessment of GORE® SYNECOR Biomaterial in Focused Patient Populations and Long-Term Application
W.L.Gore & Associates·—·active not recruiting·n = 320
Hernia, VentralHernia IncisionalHernia Incisional VentralHernia repair with mesh
brief summary
The SYN 20-01 Study is a non-interventional, prospective, multicenter, multicohort, international, post-market clinical investigation looking into the assessment of GORE® SYNECOR Biomaterial in focused patient populations and in long-term application. Patients with ventral / incisional hernia amenable to hernia mesh repair will be enrolled into two cohorts (US and EU cohort) and followed-up over the period of 60 months.
started
Feb 24, 2023
primary completion
Jul 31, 2030
completion
Jul 31, 2030
last updated
Jan 21, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol